 | Up a level |
Bargagli, Matteo; Ferraro, Pietro Manuel; Dhayat, Nasser; Anderegg, Manuel; Fuster, Daniel (2021). Effect of Tolvaptan treatment on acid-base homeostasis in ADPKD patients. Kidney international reports, 6(6), p. 1749. Elsevier 10.1016/j.ekir.2021.04.012
Bargagli, Matteo; Dhayat, Nasser A.; Anderegg, Manuel; Semmo, Mariam; Huynh-Do, Uyen; Vogt, Bruno; Ferraro, Pietro Manuel; Fuster, Daniel G. (2020). Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan. Clinical Journal of the American Society of Nephrology, 15(7), pp. 1007-1014. American Society of Nephrology 10.2215/CJN.13861119
